3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Primary Myelofibrosis
4
Leukemia, Myeloid, Acute
4
Myelodysplastic Syndromes
3
Polycythemia Vera
2
Neoplasms
2
Myeloproliferative Disorders
2
Lymphoma, T-Cell
2
Leukemia
2
Graft vs Host Disease
2
Thrombocythemia, Essential
1
Thalassemia
1
Preleukemia
1
Precancerous Conditions
1
Neoplasms by Histologic Type
1
Myelodysplastic-Myeloproliferative Diseases
1
Mycosis Fungoides
1
Multiple Myeloma
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, B-Cell
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Immunoblastic Lymphadenopathy
1
Hematologic Neoplasms
1
Hematologic Diseases
1
Glioma
1
Glioblastoma
1
Carcinoma, Non-Small-Cell Lung
1
Bronchiolitis Obliterans Syndrome
1
Bone Marrow Diseases
1
Interventions
Gemcitabine
26
Specimen Handling
20
130-nm albumin-bound paclitaxel
18
Magnetic Resonance Spectroscopy
13
Irinotecan
13
Biopsy
12
Fluorouracil
11
Leucovorin
10
Oxaliplatin
9
Cyclophosphamide
8
pembrolizumab
7
fludarabine
7
Albumin-Bound Paclitaxel
7
Cisplatin
6
Cetuximab
6
Nivolumab
5
durvalumab
4
Taxes
4
Radiosurgery
4
Pemetrexed
4
Capecitabine
4
zimberelimab
3
trastuzumab deruxtecan
3
olaparib
3
irinotecan sucrosofate
3
dehydroftorafur
3
aldesleukin
3
Radiotherapy
3
Immunoglobulin G
3
Exercise
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Pancreatic Neoplasms
×
ruxolitinib
×
30 days
×
Clear all
No trials found.